Orchard Therapeutics plc CEO Bobby Gaspar's 2021 pay rises 15% to $4.4M
Orchard Therapeutics plc reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Orchard Therapeutics plc reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, two executives at Orchard Therapeutics plc received on average a compensation package of $3.2M, a 5% decrease compared to previous year.
Average pay of disclosed executives at Orchard Therapeutics plc
Bobby Gaspar, Chief Executive Officer, received $4.4M in total, which increased by 15% compared to 2020. 80% of Gaspar's compensation, or $3.5M, was in option awards. Gaspar also received $218K in non-equity incentive plan, $605K in salary, as well as $27K in other compensation.
Frank Thomas, Chief Operating Officer, received a compensation package of $2M, which decreased by 34% compared to previous year. 64% of the compensation package, or $1.3M, was in option awards.
Related executives
You may also like
Source: SEC filing on April 27, 2022.